Intuitive Surgical, Inc. $ISRG Position Raised by Bank Pictet & Cie Europe AG

Key Points

• Bank Pictet & Cie Europe AG has increased its position in Intuitive Surgical, Inc. by 0.6%, now owning approximately 189,805 shares of the company, making it the 10th biggest holding in their investment portfolio.
• Intuitive Surgical recently reported earnings of $2.19 per share, exceeding analyst expectations and marking a 21.4% year-over-year revenue growth to $2.44 billion.
• Several brokerages have issued optimistic ratings on Intuitive Surgical, with a consensus rating of "Moderate Buy" and an average price target of $595.95.

Bank Pictet & Cie Europe AG lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 189,805 shares of the medical equipment provider's stock after acquiring an additional 1,083 shares during the period. Intuitive Surgical accounts for approximately 2.2% of Bank Pictet & Cie Europe AG's investment portfolio, making the stock its 10th biggest holding. Bank Pictet & Cie Europe AG owned about 0.05% of Intuitive Surgical worth $103,142,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Aaron Wealth Advisors LLC lifted its holdings in shares of Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider's stock worth $1,374,000 after purchasing an additional 19 shares during the period. Crown Wealth Group LLC raised its position in Intuitive Surgical by 4.8% during the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after buying an additional 20 shares during the last quarter. FSM Wealth Advisors LLC lifted its stake in Intuitive Surgical by 3.8% during the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock valued at $270,000 after acquiring an additional 20 shares during the period. CFO4Life Group LLC boosted its holdings in shares of Intuitive Surgical by 4.8% in the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock valued at $216,000 after acquiring an additional 20 shares during the last quarter. Finally, J. W. Coons Advisors LLC increased its stake in shares of Intuitive Surgical by 1.4% in the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider's stock worth $741,000 after acquiring an additional 20 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Trading Down 1.3%

Shares of ISRG stock opened at $438.12 on Friday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The business's 50 day moving average is $470.98 and its two-hundred day moving average is $501.82. The company has a market capitalization of $157.06 billion, a P/E ratio of 61.10, a P/E/G ratio of 4.65 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the prior year, the company posted $1.78 EPS. The business's quarterly revenue was up 21.4% on a year-over-year basis. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Amy L. Ladd sold 336 shares of the business's stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director owned 1,074 shares of the company's stock, valued at $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company's stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ISRG. Truist Financial increased their price target on Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. BTIG Research upped their target price on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. UBS Group raised their target price on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a report on Wednesday, July 23rd. Royal Bank Of Canada reissued an "outperform" rating and issued a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. Finally, Wells Fargo & Company upped their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.